Conclusion
This study revealed that fetal EFT was significantly increased in diabetic pregnancies with either PGDM or GDM but the increase in fetal EFT was significantly higher in PGDM compared to GDM. Furthermore, fetal EFT is strongly correlated with maternal blood glucose levels in diabetic pregnancies. Therefore, fetal EFT value could be used as a prognostic marker for PGDM and GDM and also for adverse perinatal outcomes related to diabetes.
Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Disclosure of interest: The authors report no conflict of interest.
Informed consent: Informed consent was obtained from all individuals included in this study.
Ethical approval: The research related to human use complied with all the relevant national regulations, instutional policies, and in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ Institutional Review Board or equivalent committee (Izmir Tepecik Training and Research Hospital Ethics Committee, decision no: 2021/02-50)